Top

Published in:

Open Access 01-11-2010 | Poster presentation

Atopy in cutaneous and arthropatic psoriasis

Authors: E Hajdarbegovic, AAA Westgeest, H B Thio

Published in: Journal of Translational Medicine | Special Issue 1/2010

Excerpt

Psoriasis is a chronic inflammatory disease where keratinocytes are stimulated to hyperplasia by immunocytes organised in a Th17/Th1-type (T- helper cell) dominated response.[1, 2] In about 15% of the patients with psoriasis, arthritis will develop.[3, 4] There have been studies which demonstrated antagonism between atopy and mainly Th-1 driven inflammatory and autoimmune diseases such as rheumatoid arthritis in which the presence of atopy confers a milder course of the disease.[5] …

Nograles KE, Brasington RD, Bowcock AM: New insights into the pathogenesis and genetics of psoriatic arthritis. Nat Clin Pract Rheumatol . 2009, 5 (2): 83-91. 10.1038/ncprheum0987.PubMedCentralCrossRefPubMed

Di Cesare A, Di Meglio P, Nestle FO: The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol . 2009, 129 (6): 1339-50. 10.1038/jid.2009.59.CrossRefPubMed

Ibrahim G, Waxman R, Helliwell PS: The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum. 2009, 61 (10): 1373-8. 10.1002/art.24608.CrossRefPubMed

van Romunde LK: Psoriasis and arthritis. I. A population study. Rheumatol Int. 1984, 4 (2): 55-60. 10.1007/BF00541197.CrossRefPubMed

Rabin RL, Levinson AI: The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literature. Clin Exp Immunol. 2008, 153 (1): 19-30. 10.1111/j.1365-2249.2008.03679.x.PubMedCentralCrossRefPubMed

Chen ZY: Immunoglobulin E in psoriasis evaluated by paper radioimmunosorbent and paper enzyme-immunosorbent tests. Acta Derm Venereol. 1985, 65 (1): 14-8.PubMed

Pigatto PD: Atopy and contact sensitization in psoriasis. Acta Derm Venereol Suppl (Stockh). 2000, 19-20. 10.1080/00015550050500077. 211

Welp K: [Concomitant psoriasis vulgaris and atopic dermatitis. A study of 1,065 patients with psoriasis] Koinzidenz von Psoriasis vulgaris und atopischer Dermatitis. Eine Untersuchung an 1,065 Psoriasis-Patienten. Hautarzt. 1989, 40 (8): 496-500.PubMed

Ovcina-Kurtovic N, Kasumagic-Halilovic E: Serum levels of total immunoglobulin E in patients with psoriasis : relationship with clinical type of disease. Med Arh. 2010, 64 (1): 28-9.PubMed

10.

Negosanti M: IgE serum levels in psoriasis. Dermatologica. 1981, 163 (6): 474-5. 10.1159/000250218.CrossRefPubMed

Title: Atopy in cutaneous and arthropatic psoriasis
Authors: E Hajdarbegovic
AAA Westgeest
H B Thio
Publication date: 01-11-2010
Publisher: BioMed Central
Published in: Journal of Translational Medicine / Issue Special Issue 1/2010
Electronic ISSN: 1479-5876
DOI: https://doi.org/10.1186/1479-5876-8-S1-P15

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Atopy in cutaneous and arthropatic psoriasis

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2010

Cytokines and apoptosis genes polymorphisms influence the outcome of hepatitis C virus infection

Influence of a polymorphism IL1B gene in the response of rheumatoid arthritis and ankylosing spondylitis patients treated with infliximab

Differential association of two PTPN22 coding variants with Crohn’s disease and ulcerative colitis

Patients with non-relapsing ANCA-associated vasculitis have increased numbers of circulating IL-10 producing Th17 cells

Crohn’s disease is caused by a failure of the innate immune response with major abnormalities in macrophage biology

Inflammatory T-lymphocyte proliferation in morbid obesity

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page